Upload
kym-anne-surmion-ii
View
68
Download
3
Tags:
Embed Size (px)
Citation preview
Xenobiotics
O substances foreign to the body
O include environmental pollutants, food additives, cosmetic chemicals, agrochemicals, processed foods, and DRUGS.
O substances entering the body are relatively LIPOPHILIC (fat-loving or lipid soluble)
Xenobiotics
O If lipophilic drugs were not metabolized to polar, readily excretable products, they would remain indefinitely in the body, eliciting their biological effects. Hence,
No Metabolism Accumulation Toxicity
Drug Metabolism
O conversion of lipophilic (hydrophobic) compounds into hydrophilic (lipophobic) derivatives that are readily eliminated in urine or bile.
Drug Metabolism
O the formation of water-soluble metabolites not only enhances drug elimination, but also leads to compounds that are generally pharmacologically inactive and relatively nontoxic.
Drug Metabolism
O drug interactions are based on metabolic processes
O Pharmacists: To understand why certain drugs are contraindicated with other drugs
Drug Metabolism
PRODRUGS
O drugs biotransformed to pharmacologically active metabolites
O usually, parent compound is inactive when administered and must be metabolically converted to a biologically active drug
Drug Metabolism
Inactive Parent Compound Active Metabolite
O Sulindac (NSAID) O Sulfide Metabolite
Reduction
Drug Metabolism
Inactive Parent Compound Active Metabolite
O Azathioprine (Immunosuppresant)
O 6 – Mercapturine
Cleavage
Drug Metabolism
Inactive Parent Compound Active Metabolite
O Acyclovir (Antiviral) O Acyclovir triphosphate
Phosphorylation
Drug Metabolism
Active Parent Compound Active Metabolite
O Phenacetin (Analgesic)
O Acetaminophen
O-dealkylation
Drug Metabolism
Active Parent Compound Active Metabolite
O Imipramine
O Amitriptyline
(TCADs)
O Desipramine
O Nortriptyline
N-demethylation
Sites of Biotransformation
LIVERO most important organ in drug metabolism
INTESTINAL MUCOSAO important site of metabolism for orally
administered drugs
KIDNEYS, LUNGS, ADRENAL GLANDS, PLACENTA, BRAIN, SKINO substrate selective and more limited to
particular types of reaction
First Pass Effect
O phenomenon in drug metabolism whereby the concentration of drug is greatly reduced before it reaches the systemic circulation
O orally administered drugs that are absorbed into the bloodstream through the GI tract are susceptible for they must pass through the liver before further distributed into the system
Drugs Metabolized by the First Pass Effect
OLidocaine
OIsoproterenol
ONitroglycerin
OSalicylamide
OPropranolol
OPropoxyphene
OPentazocine
OMeperidine
OMorphine
Role of Enzymes in Biotransformation
Enzymes Reactions
Cytochrome P450s (CYP) C and O oxidation, dealkylation
Flavin-containing Monooxygenases (FMO)
N, S, and P oxidation
Epoxide hydrolases (mEHand sEH)
Hydrolysis of epoxides
Alcohol dehydrogenases Reduction of alcohols
Aldehyde dehydrogenases Reduction of aldehydes
Role of Enzymes in Biotransformation
Enzymes Reactions
Sulfotransferases (SULT) Addition of Sulfate
UDP-glucoronosyltransferases(UGT)
Addition of Glucoronic acid
Glutathione-S-transferases(UST)
Addition of Glutathione
N-acetyltransferases (NAT) Addition of Acetyl group
Methyltransferases (MT) Addition of Methyl group
Reaction Cycle involving Cytochrome p-450 in the oxidation of xenobiotics
Steps involved:
1. Drug substrate binds to CYP450
2. CYP450-Drug complex is reduced by NADPH
3. Molecular oxygen (O2) binds to the reduced CYP450-Drug complex
4. One atom of oxygen combines with the drug substrate, the other atom forms water
5. Oxygen is reduced to an “activated” state
6. The enzyme complex dissociates to yield free oxygenated drug metabolite
Pathways of Drug Metabolism
Phase I Reactions
O Oxidative reactions
O Reductive reactions
O Hydrolytic reactions
Phase II Reactions
O Glucuronic acid conjugation
O Sulfate conjugation
O Amino acid conjugation
O Glutathione or mercapturic acid conjugation
O Acetylation
O Methylation
Phase I Functionalization Reactions
O introduce functional polar groups (e.g., -OH, -COOH, -NH2, -SH) into the compound to produce a more water-soluble compound.
O may not produce sufficiently hydrophilic or inactive metabolites.
O the functional group on the molecule attached can undergo subsequent phase II reactions.
Phase I Functionalization Reactions
Direct Introduction of Functional Group
O Aromatic and Alipathic Hydroxylation
Phase I Functionalization Reactions
Modification of Existing Functionalities
O Reduction
RCOR/RCHO ROH (Alcohol)
azo/nitro groups RNH2 (Amine)
Phase I Functionalization Reactions
Modification of Existing Functionalities
O Oxidation
O ROH RCHO (Aldehyde)
O RCHO RCOOH (Carboxylic Acid)
O N, O, S -NH2, -OH, -SH
Phase I Functionalization Reactions
Modification of Existing Functionalities
O Hydrolysis
O esters/amides RCOOH
ROH RNH2
Phase II Conjugation Reactions
O attaches small, polar, and ionizableendogenous compounds (e.g. glucuronicacid, sulfate, glycine, and other amino acids) to the “handle” of phase I metabolites or parent compounds to form water-soluble CONJUGATED PRODUCTS – devoid of pharmacological activity
Phase II Conjugation Reactions
O Glucuronic acid conjugation
O Sulfate conjugation
O Amino acid conjugation (Glycine and Glutamine)
O Glutathione or mercapturic acid conjugation
O Acetylation
O Methylation
Pathways of Drug Metabolism
In Conclusion,
Phase I and II reactions complement one another in detoxifying and facilitating the elimination of drugs and xenobiotics.
e.g. Δ1 – tetrahydrocannabinol (principal psychoactive constituent of marijuana)
Factors Affecting Drug Metabolism
Age DifferencesO oxidative and conjugative capabilities:
Newborn vs. Adult
Ooxidative metabolism of Tolbutamide is lower in newborns: t1/2 40 hrs; adults: t1/2 8 hrs
O inability of babies to glucuronidate Bilirubinleads to neonatal hyperbilirubinemia or Kernicterus
O inability of babies to conjugate Chloramphenicol results to Gray Baby Syndrome
Factors Affecting Drug Metabolism
Species and Strain Differences
O metabolism of drugs and foreign compounds is species dependent
O Amphetamine
O Humans, Rabbits, Guinea Pigs –
undergoes oxidative deamination
O Rats – undergoes aromatic hydroxylation
Factors Affecting Drug Metabolism
Species and Strain Differences
O Amphetamine
O Humans, Rabbits, Guinea Pigs – undergoes oxidative deamination
O Rats – undergoes aromatic hydroxylation
O Cats – poor glucuronidation; good sulfation
O Pigs – poor sulfation; poor glucuronidation
Factors Affecting Drug Metabolism
Species and Strain Differences
O even within the same species, individual variations (strain differences) may result in differences of specific metabolic pathways
O Acetylation
O Orientals and Eskimos – rapid acetylators
O Mediterrenean Jews and Egyptians – slowacetylators
Factors Affecting Drug Metabolism
Hereditary or Genetic Factors
O marked individual differences in the metabolism of several drugs exist in humans
Factors Affecting Drug Metabolism
Sex Differences
O species dependent
O significant in terms of drug-drug interactions based on the drug’s metabolism
O e.g. Aspirin and Nicotine are metabolized differently in men and women
Factors Affecting Drug Metabolism
Enzyme InductionO increased activity of drug metabolizing
enzymes
O increases the rate of drug metabolism and decreases the duration of drug action
O e.g. Phenobarbital and Warfarin: induction of phenobarbital increases the metabolism of warfarin which decreases the anticoagulant effect of the drug
Factors Affecting Drug Metabolism
Enzyme InhibitionO decreased activity of drug metabolizing
enzymes
O with decreased metabolism, the drug accumulates, leading to prolonged drug action and serious adverse effects
O e.g. grapefruit-drug interactions Carbamazepine (Tegretol), Atorvastatin(Lipitor), etc
Factors Affecting Drug Metabolism
Miscellaneous Factors
O Dietary Factors
O protein-carbohydrate ratio
O indoles present in vegetables
O polycyclic aromatic hydrocarbons in charcoal-broiled beef
O vitamins, minerals, starvation, malnutrition